ALB and cancer: An alternative strategy to enhance cancer cell accumulation and improve the pharmacokinetic profile of RGD peptides could involve increasing their affinity for plasma proteins—particularly serum albumin—to extend circulation time and promote tumor accumulation through the enhanced permeability and retention (EPR) effect and albumin-mediated transport [18].